Concurrent Session 11: Therapeutic Challenges in OA

Concurrent Session

Date/Time: Saturday, May 1, 2021 - 2:45 PM to 4:45 PM
Log in to Add to My Schedule

Description:

Digital Health Approaches for the Lifestyle Management of Osteoarthritis
The burden from osteoarthritis is expected to increase in coming decades as the world’s population ages, and obesity rates continue to rise. A substantial increase in demand for health services is expected in the future to manage people with chronic joint pain. Self-management via lifestyle treatments, such as exercise/physical activity and weight loss, is integral to minimizing pain and maintaining physical function. However, OA care is suboptimal worldwide with underuse of lifestyle treatments a major problem. There are numerous barriers to uptake of and adherence to lifestyle treatments. One major barrier is difficulty accessing clinicians and/or resources (due to covid restrictions, geography, lack of clinicians, cost, inconvenience & disability). Given the high adoption rate of computers, mobile devices and internet globally and the new reality of the COVID-19 pandemic, online approaches provide opportunities for delivering services remotely to people with OA and supporting them to self manage. These approaches include internet-mediated video conferencing, mobile phone services, web resources & online support groups. Evidence for effectiveness of such approaches will be reviewed. Key challenges to implementation and future directions for research in the field will be highlighted

Abstract(s):

  • 91. OBSERVED EFFICACY OF SUBCUTANEOUS TANEZUMAB OR ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH OSTEOARTHRITIS: SUBGROUP ANALYSES OF A PHASE 3 STUDY
    D. J. Hunter1, S. Radominski2, S. Rodriguez Ulloa3, I. Goranov4, G. Radunovic5, C. Chang6, G. Pixton7, A. Hickman8, R. J. Fountaine8, M. T. Brown8, L. Viktrup9, C. West8; 1Univ. of Sydney, Sydney, Australia, 2Univ.e Federal do Paraná, Curitiba, Brazil, 3Hosp. de Alta Complejidad Virgen de la Puerta, Trujillo, Peru, 4Univ. Hosp. Plovdiv, Plovdiv, Bulgaria, 5Inst. of Rheumatology, Univ. of Belgrade, Belgrade, Serbia, 6Seoul Natl. Univ. Coll. of Med., Seoul Natl. Univ. Bundang Hosp., Seongnam-si, Korea, Republic of, 7Pfizer Inc., Morrisville, NC, 8Pfizer Inc., Groton, CT, 9Eli Lilly and Company, Indianapolis, IN

  • 92. PHYSICAL THERAPY FOR KNEE OSTEOARTHRITIS IS COST-EFFECTIVE COMPARED TO INTRA-ARTICULAR GLUCOCORTICOID INJECTION AT 1 YEAR: ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL
    D. I. Rhon1,2, M. Kim3, C. V. Asche3, S. Allison1, C. S. Allen4, G. D. Deyle1; 1Brooke Army Med. Ctr., JBSA, TX, 2Dept. of Rehab Med., Uniformed Services Univ. of Hlth.Sci., Bethesda, MD, 3Univ. of Illinois Coll. of Med. at Peoria, Peoria, IL, 4Coll. of Allied Hlth.Sci., Univ. of Cincinnati, Cincinnati, OH

  • 93. PATIENT-REPORTED ACTIVITY LIMITATIONS IN HIP AND KNEE OSTEOARTRITIS IN PRIMARY CARE
    T. Moseng1, H. Dagfinrud1, B. Natvig2, N. Østerås1; 1Diakonhjemmet Hosp., Oslo, Norway, 2Univ. of Oslo, Oslo, Norway

  • 94. THE OARSI "JOINT EFFORT INITIATIVE" REPOSITORY OF ONLINE OSTEOARTHRITIS MANAGEMENT PROGRAMMES: AN IMPLEMENTATION RAPID RESPONSE DURING COVID-19
    J. G. Quicke1, L. R. Swaithes1, L. H. Campbell1, J. L. Bowden2, J. P. Eyles2, K. D. Allen3, D. J. Hunter2, K. L. Bennell4, H. S. R4, D. Schiphof5, M. V. Hurley6, N. E. Walsh7, L. E. Dahlberg8, D. Bossen9, K. S. Dziedzic1, OARSI Joint Effort Initiative Implementation group; 1Keele Univ., Staffordshire, United Kingdom, 2Univ. of Sydney, Sydney, Australia, 3Univ. of North Carolina, Chapel Hill, NC, 4Univ. of Melbourne, Melbourne, Australia, 5Erasmus Univ., Rotterdam, Netherlands, 6Saint Georges Univ. of London and Kingston Univ., London, United Kingdom, 7Univ. of the West of England, Bristol, United Kingdom, 8Lund Univ., Malmo, Sweden, 9Amsterdam Univ. of Applied Sci., Amsterdam, Netherlands

  • 95. SINGLE CELL RNA SEQUENCING OF DORSAL ROOT GANGLIA IDENTIFIES UNDERSTUDIED DRUGGABLE TARGETS FOR OSTEOARTHRITIS PAIN
    R. E. Miller, L. Wang, S. Ishihara, R. J. Miller, A-M. Malfait; Rush Univ. Med. Ctr., Chicago, IL

  • 96. DIGITALLY DELIVERED FIRST-LINE OSTEOARTHRITIS TREATMENT IMPROVES PAIN EQUALLY WELL FOR PARTICIPANTS OLDER THAN 70 AND FOR THOSE IN YOUNGER AGE GROUPS
    L. S. Lohmander1, M. Misini Ignjatovic2, L. E. Dahlberg1, H. Nero1; 1Lund Univ., Lund, Sweden, 2Arthro Therapeutics, Malmö, Sweden

Speaker(s):